H.R. 326 · 115th Congress
Neuromyelitis Optica Consortium Act
- Stage
- In committee
- Sponsor
- Barbara Lee
- Introduced
- 2017-01-05
- Latest action
- 2017-01-25 · Referred to the Subcommittee on Health.
Summary
Neuromyelitis Optica Consortium Act
This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis. The consortium must:
award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO; assemble a panel of experts to provide guidance and recommendations on research design and protocols; and designate a central laboratory to collect and analyze data from this research and to make the data and analysis available to researchers.